Start
•
Completion

Single Ascending Dose Study With BPL-003 in Healthy Subjects

CompletedRegisteredCTG

Randomised Phase I single ascending-dose intranasal study (n=62) evaluating safety, tolerability and pharmacokinetics of BPL-003 (5‑MeO‑DMT) in healthy adults.

Details

A randomised, sequential single ascending-dose study in healthy adults testing single intranasal doses of BPL-003 (5‑MeO‑DMT) versus placebo.

Primary outcomes are safety and tolerability; secondary outcomes include pharmacokinetic profiling. Masking noted as quadruple (Part A only) in the registry.

Topics:Healthy Volunteers

Registry

Registry linkNCT05347849